VOLUME 11 (2020)
View Archive »
About The Cover
The cover for issue 49 of Oncotarget features Figure 4, "CART-Tree analysis for overall survival in IMDC intermediate risk group," by Guida, et al.
|
|
Table of Contents
Editorial
|
| Unraveling the role of fibroblasts, FGF5 and FGFR2 in HER2-targeted therapies resistance and tumor progression |
|
https://doi.org/10.18632/oncotarget.27829
Paloma Bragado, Patricia Fernández-Nogueira, Neus Carbó, Pere Gascón
|
| 4541-4543 |
Research Perspectives
|
| Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapies |
|
https://doi.org/10.18632/oncotarget.27841
Ahmad A. Nazem, Jacob Ruzevick, Manuel J. Ferreira Jr
|
| 4544-4553 |
Research Papers
|
| High-fat diet-fed ovariectomized mice are susceptible to accelerated subcutaneous tumor growth potentially through adipose tissue inflammation, local insulin-like growth factor release, and tumor associated macrophages |
|
https://doi.org/10.18632/oncotarget.27832
Jackie Bader, Meredith Carson, Reilly Enos, Kandy Velazquez, Alexander Sougiannis, Udai Singh, William Becker, Mitzi Nagarkatti, Daping Fan, Angela Murphy
|
| 4554-4569 |
|
| Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites |
|
https://doi.org/10.18632/oncotarget.27827
Judith E. den Ouden, Guido J.R. Zaman, Jelle Dylus, Antoon M. van Doornmalen, Winfried R. Mulder, Yvonne Grobben, Wilhelmina E. van Riel, Joanne A. de Hullu, Rogier C. Buijsman, Anne M. van Altena
|
| 4570-4581 |
|
| Identification of international metastatic renal cell carcinoma database consortium (IMDC) intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.27762
Annalisa Guida, Gwénaël Le Teuff, Carolina Alves, Emeline Colomba, Vincenzo Di Nunno, Lisa Derosa, Ronan Flippot, Bernard Escudier, Laurence Albiges
|
| 4582-4592 |
|
| The inhibitory effect of TU-100 on hepatic stellate cell activation in the tumor microenvironment |
|
https://doi.org/10.18632/oncotarget.27835
Yuma Wada, Kazunori Tokuda, Yuji Morine, Shohei Okikawa, Shoko Yamashita, Tetsuya Ikemoto, Satoru Imura, Yu Saito, Shinichiro Yamada, Mitsuo Shimada
|
| 4593-4604 |
Corrections
|
| Correction: MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells |
|
https://doi.org/10.18632/oncotarget.27716
Xiaoping Liu, Qianqian Lei, Zhibin Yu, Gang Xu, Hailin Tang, Wei Wang, Zeyou Wang, Guiyuan Li, Minghua Wu
|
| 4605-4606 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
